Cancer Genomics: From Bench to Personalized Medicine
Editat de Graham Dellaire, Jason N Berman, Robert J. Arcecien Limba Engleză Hardback – 14 ian 2014
- Tools such as sidebars, key concept summaries, a glossary, and acronym and abbreviation definitions make this book highly accessible to researchers from several fields associated with cancer genomics.
- Contributions from thought leaders provide valuable historical perspective to relate the advances in the field to current technologies and literature.
Preț: 663.30 lei
Preț vechi: 864.97 lei
-23% Nou
Puncte Express: 995
Preț estimativ în valută:
126.98€ • 131.99$ • 105.28£
126.98€ • 131.99$ • 105.28£
Carte tipărită la comandă
Livrare economică 30 ianuarie-13 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780123969675
ISBN-10: 0123969670
Pagini: 510
Dimensiuni: 216 x 276 x 30 mm
Greutate: 1.66 kg
Editura: ELSEVIER SCIENCE
ISBN-10: 0123969670
Pagini: 510
Dimensiuni: 216 x 276 x 30 mm
Greutate: 1.66 kg
Editura: ELSEVIER SCIENCE
Public țintă
Academic researchers, clinicians, industrial and pharmaceutical scientists who are involved in fundamental or commercial research regarding cancer genomics. Graduate students in Cancer Biology, Genetics, Biochemistry, Molecular Biology and related disciplinesCuprins
Introduction1. Historical Overview
Methodological Approaches and Background2. Expression Arrays (SNPs, etc.)3. Tissue micro-arrays (breast, ovarian) 4. Next generation sequencing (DNAseq) 5. RNAseq (breast cancer, sarcomas)6. Epigenetic Analyses7. Pharmcogenomics8. Biomarker discovery through genomics 9. Preclinical models for genomics (cell culture, transgenic animals, xenografts) 10. Bioinformatics and computational methods for data analysis11. Genomic Resource Projects – The Cancer Genome Atlas (TCGA) International Cancer Genome Consortium (ICGC)
Ethics of Genomics Research 12. Ethics of Genomics Research
The Genomics, Epigenomics and Transcriptomics of Cancer13. Somatic mutations, Transcription and Epigenetics Overview
Adult Solid Tumors14. Lung Cancer15. Breast Cancer16. Prostate Cancer17. Colon Cancer18. Thyroid Cancer
Age Non-specific Tumors and Hematopoietic Malignancies19. ALL 20. AML21. NHL22. Multiple Myeloma23. Brain Tumors
Pediatric Cancers24. Neuroblastoma25. Soft tissue sarcomas26. Osteosarcoma27. Wilms Tumors
Germline Mutations and Hereditary Cancer Syndromes 28. Germline Mutations and Hereditary Cancer Syndromes
Future Directions29. The role of microRNAs and ultraconserved non-coding RNAs in cancer30. Environmental impact on cancer genomics
Methodological Approaches and Background2. Expression Arrays (SNPs, etc.)3. Tissue micro-arrays (breast, ovarian) 4. Next generation sequencing (DNAseq) 5. RNAseq (breast cancer, sarcomas)6. Epigenetic Analyses7. Pharmcogenomics8. Biomarker discovery through genomics 9. Preclinical models for genomics (cell culture, transgenic animals, xenografts) 10. Bioinformatics and computational methods for data analysis11. Genomic Resource Projects – The Cancer Genome Atlas (TCGA) International Cancer Genome Consortium (ICGC)
Ethics of Genomics Research 12. Ethics of Genomics Research
The Genomics, Epigenomics and Transcriptomics of Cancer13. Somatic mutations, Transcription and Epigenetics Overview
Adult Solid Tumors14. Lung Cancer15. Breast Cancer16. Prostate Cancer17. Colon Cancer18. Thyroid Cancer
Age Non-specific Tumors and Hematopoietic Malignancies19. ALL 20. AML21. NHL22. Multiple Myeloma23. Brain Tumors
Pediatric Cancers24. Neuroblastoma25. Soft tissue sarcomas26. Osteosarcoma27. Wilms Tumors
Germline Mutations and Hereditary Cancer Syndromes 28. Germline Mutations and Hereditary Cancer Syndromes
Future Directions29. The role of microRNAs and ultraconserved non-coding RNAs in cancer30. Environmental impact on cancer genomics
Recenzii
"…provides a snapshot of the current issues and state-of-the-art technologies used in cancer genomics. Subsequent chapters highlight how these approaches have informed our understanding of hereditary cancer syndromes and the diagnosis, treatment and outcome in a variety of adult and pediatric solid tumors and hematologic malignancies." --Anticancer Research 34, 2014